NEW YORK (Reuters Health) – Findings from a systematic review indicate that while tamoxifen, raloxifene, and tibolone all reduce the risk of primary breast cancer, the drugs differ…
NEW YORK (Reuters Health) – A dexamethasone-based protocol can cut the risk of relapse and improve survival in high-risk children with acute lymphoblastic leukemia (ALL), with fewer side…
NEW YORK (Reuters Health) – Thiazolidinedione treatment of diabetes in older adults is associated with an increased fracture risk, according to a report in the August issue of…
NEW YORK (Reuters Health) – Intracoronary streptokinase (ICSK) given immediately after percutaneous coronary intervention (PCI) reduces long-term myocardial infarction size and improves left ventricular volumes and function, Turkish…
NEW YORK (Reuters Health) – When metformin and a sulphonylurea or a glinide fail to bring type 2 diabetes under control, adding pioglitazone may do the trick, French…
NEW YORK (Reuters Health) – High-dose N-acetylcysteine decreases the incidence of contrast-induced nephropathy, results of a meta-analysis indicate. “N-acetylcysteine has the advantages of being relatively innocuous, inexpensive, and…
NEW YORK (Reuters Health) – Hurricane Katrina brought many changes to hospitals that remained open throughout the hurricane and during its aftermath. Among these were greater efficiency as…
NEW YORK (Reuters Health) – Giving low-dose dopamine to brain-dead donors can improve graft function after kidney transplantation, according to trial findings reported in the Journal of the…
NEW YORK (Reuters Health) – Rectal diclofenac, oral ibuprofen, and oral acetaminophen are ineffective for preventing recurrences of febrile seizures in children, new research suggests. Moreover, such agents…
NEW YORK (Reuters Health) – Imipenem-resistant Pseudomonas aeruginosa (IRPA) is an emerging problem and, in the ICU, patient-to-patient transmission may occur, even in the absence of an outbreak,…